ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Clinical trial NCT00300196 · TERMINATED

Trial details

NCT number: NCT00300196
Sponsor: Neurobiological Technologies
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke Cerebral Ischemia Brain Infarction

Start date: 2006-03-01
Primary completion: 2008-12-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.